Propagation of phage genomes in bacterial hosts can be toxic to the host, thus limiting the efficiency of phage genome engineering using methods such as homologous recombination, BRED, and in vivo recombineering. This problem can be overcome by using Saccharomyces cerevisiae rather than bacteria as an intermediate host for genetic manipulation. Homologous recombination is particularly efficient in Saccharomyces cerevisiae, and the phage genome does not cause toxicity in yeast and can be stably maintained. Using this method, phage genomes were captured in a Saccharomyces cerevisiae-bacteria shuttle vector. Phage genomes assembled, modified, and propagated in yeast have been isolated and introduced into bacteria to generate functional phage particles. This technology has been used to capture and genetically modify the genomes of E. coli phages T3 (38,208 bp) and T7 (39,937 bp) and Klebsiella phage K11 (41,181 bp). It was further used to capture and archive the genome of the fully reconstituted phage φX174 (6,302 bp).
Creative Biolabs has been committed to phage engineering for a long time and has accumulated rich experience in the development of different engineered phages such as reporting phages, labeled phages, therapeutic phages, etc. Our services are listed as follows, but are not limited to:
Creative Biolabs can meet the needs of customers by providing yeast-based assembly of bacteriophage genomes services on time and on budget. We have in-depth knowledge and experience of the tools and processes involved in the phage projects. Our skilled and dedicated scientific researchers ensure that the most suitable methods and techniques are selected for your project. If necessary, please feel free to contact us.
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.